Back to VANGUARD GROUP INC VANGUARD GROUP INC

KLRSKLRS
4 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in KALARIS THERAPEUTICS INC

As of its last 13F, for Q4 2025, Vanguard Group held 292,790 shares of KLRS (Kalaris Therapeutics), worth $2.5M. It increased the position by 89,739 shares (+44.2%) from Q3 2025. Vanguard Group held KLRS from Q1 2025 to Q4 2025, across 4 quarterly 13F filings.

Current Value

$2.5M

Current Shares

292,790

Total Value Change

+$1.5M

Total Shares Change

+177,704

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
292,790
+44.2%
$2.5M0.0%$8.38
24
2025-Q3
Increased
203,051
+56.4%
$1.2M0.0%$6.35
24
2025-Q2
Increased
129,839
+12.8%
$346,6700.0%$2.62
18
2025-Q1
New
115,086
-
$924,1410.0%$8.60
38

Other major holders of KLRS: RTW INVESTMENTS, LP, Alyeska Investment Group, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used